Five decades of therapy for multiple myeloma: a paradigm for therapeutic models-Reference-Cited by-同舟云学术

Five decades of therapy for multiple myeloma: a paradigm for therapeutic models

Published:2005-03-31 Issue:6 Volume:19 Page:910-912
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Kyle R A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2403728.pdf

Reference22 articles.

1. Kyle RA . Multiple myeloma: how did it begin? Mayo Clin Proc 1994; 69: 680–683.

2. Paul JR . Stanhope Bayne-Jones (1888–1970). Medical dean, military hero, microbiologist and epidemiologist, and medical historian. Yale J Biol Med 1972; 45: 22–32.

3. Korngold L, Lipari R . Multiple-myeloma proteins. III. The antigenic relationship of Bence Jones proteins to normal gammaglobulin and multiple-myeloma serum proteins. Cancer 1956; 9: 262–272.

4. Korngold L, Lipari R . Multiple-myeloma proteins. I. Immunological studies. Cancer 1956; 9: 183–192.

5. Edelman GM, Gally JA . The nature of Bence Jones proteins. Chemical similarities to polypetide chains of myeloma globulins and normal gamma-globulins. J Exp Med 1962; 116: 207–227.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What’s Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple Myeloma;Targeted Oncology;2022-06-30

2. Regulation of CD38 on Multiple Myeloma and NK Cells by Monoclonal Antibodies;International Journal of Biological Sciences;2022

3. Epidemiology, genetics and treatment of multiple myeloma and precursor diseases;International Journal of Cancer;2021-08-30

4. Molecular mechanisms of antitumor activity of niclosamide;Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry;2015-10

5. Intravenous Busulfan and Melphalan as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Matched Comparison to a Melphalan-Only Approach;Biology of Blood and Marrow Transplantation;2013-01